Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 450 participants.

Also called NCT05503199

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 450 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05503199
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05503199. Randomized; no masking; primary purpose treatment. Start 2022-10-01 (actual); primary completion 2024-04-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation
Acronym
ACCESS-TAVI
Condition
Aortic Valve Stenosis
Intervention (Device)
Combination of one Perclose ProGlide or ProStyle (Abbott Vascular) and one Angio-Seal (Terumo).
Intervention (Device)
Combination of two ProGlides or ProStyles (Abbott Vascular).
Lead sponsor
Deutsches Herzzentrum Muenchen (class: other)

Record details

Record id
cardio:ct-nct05503199
Content hash
807d99aa161152f2cdcddbcfbcd78bc850cb19b1a5a537b59105d012b8e66cca